Proton pump inhibitors, medications that reduce stomach acid, may weaken bones and increase fracture risk with long-term use, according to a 2026 review in EFORT Open Reviews. These drugs interfere with calcium and magnesium absorption and disrupt bone cell activity, potentially raising fracture rates in adults and complicating bone healing after surgery. People taking PPIs regularly should discuss bone health monitoring with their doctors.
Proton pump inhibitors, commonly called PPIs, are popular medications that reduce stomach acid and are used by millions of people worldwide. According to Gram Research analysis, these drugs may have hidden effects on bones and joints that doctors are only now fully understanding. A new review of scientific studies shows that long-term PPI use could increase fracture risk, contribute to arthritis, and interfere with bone healing after surgery. While PPIs are generally considered safe for short-term use, the research suggests people taking them for years should discuss potential bone health risks with their doctors and may need extra monitoring or preventive measures.
Key Statistics
A 2026 narrative review published in EFORT Open Reviews found that long-term proton pump inhibitor use increases fracture risk in adults by interfering with calcium absorption and bone cell function.
Research reviewed by Gram shows that proton pump inhibitors may interfere with bone healing after fractures and compromise the success of hip and knee replacement surgery by disrupting the bone integration process.
According to the 2026 review, proton pump inhibitors reduce absorption of calcium, magnesium, and vitamin B12, three nutrients essential for bone strength and overall skeletal health.
The Quick Take
- What they studied: How proton pump inhibitors, medications that reduce stomach acid, might affect bones, joints, and the body’s ability to heal fractures
- Who participated: This was a review article that analyzed existing research studies rather than conducting a new experiment with participants
- Key finding: Research shows PPIs may increase fracture risk in adults and could interfere with bone healing and joint replacement surgery outcomes
- What it means for you: If you take PPIs regularly for heartburn or acid reflux, talk to your doctor about bone health. You might benefit from calcium and vitamin D supplements, bone density screening, or periodic medication reviews to see if you still need the drug
The Research Details
This study was a narrative review, meaning researchers read through many published scientific papers about PPIs and bone health, then summarized what they found. Rather than running new experiments, the authors looked at existing evidence to understand how these medications might damage bones and joints. They examined studies showing how PPIs work in the body, what happens to calcium and magnesium absorption when you take them, and clinical reports of fractures and joint problems in people using these drugs long-term. This type of review helps doctors understand patterns and connections that might not be obvious from single studies alone.
A review approach is important here because bone damage from medications develops slowly over years, making it hard to study in short-term experiments. By looking at many studies together, researchers can spot patterns and understand the full picture of how PPIs affect the skeleton. This helps doctors make better decisions about who should take these drugs and for how long.
This review was published in a peer-reviewed medical journal, meaning other experts checked the work before publication. However, because it reviews existing studies rather than conducting new research, the strength of conclusions depends on the quality of studies reviewed. The authors identified specific biological mechanisms explaining how PPIs damage bones, which adds credibility. Readers should note this is a narrative review, which is more flexible but potentially less systematic than a structured meta-analysis that uses strict criteria to select studies
What the Results Show
Research shows that PPIs can harm bones through multiple pathways. First, these medications reduce stomach acid, which is needed to absorb calcium, magnesium, and vitamin B12, all essential for bone strength. Second, PPIs interfere with specialized bone cells called osteoclasts and immune cells called granulocytes, disrupting the normal process of bone remodeling where old bone is removed and new bone is built. Third, multiple studies report that people taking PPIs for extended periods have higher rates of fractures, particularly in the hip, wrist, and spine. The risk appears to increase with longer use and higher doses. Fourth, emerging evidence suggests PPIs may increase osteoarthritis risk and can interfere with bone healing after fractures or joint replacement surgery, potentially compromising the success of hip and knee implants.
The review highlights that PPIs affect nutrient absorption beyond just calcium. Vitamin B12 deficiency from long-term PPI use can cause nerve damage and anemia. Magnesium deficiency contributes to muscle weakness and bone fragility. The timing of PPI use matters: people who take these drugs continuously for years face greater risks than those using them occasionally. The review also notes that older adults and people with existing bone weakness are at highest risk for fracture complications from PPI use.
Earlier research considered PPIs very safe because they work well for their intended purpose and have few immediate side effects. However, as more people have taken PPIs for longer periods, doctors have noticed patterns of bone problems that weren’t apparent in early studies. This review synthesizes that newer evidence, showing that while PPIs remain valuable medications, their long-term bone effects require more attention than previously recognized. The findings align with growing concern about medication side effects that only emerge after years of use.
This review has several important limitations. It doesn’t provide a precise number of how much fracture risk increases because different studies measured this differently. The review couldn’t determine whether PPIs directly cause bone problems or whether they contribute to existing risk factors. Some studies reviewed were small or had other design weaknesses. The review doesn’t distinguish between different types of PPIs or doses, so recommendations can’t be tailored to specific medications. Finally, because this is a narrative review rather than a systematic analysis, the selection of studies reviewed may reflect author bias
The Bottom Line
People taking PPIs should discuss bone health with their doctor, especially if using these drugs for more than a year. Consider calcium and vitamin D supplementation (1000-1200 mg calcium and 600-800 IU vitamin D daily for adults). Ask your doctor about periodic bone density screening, particularly if you’re over 50 or have other fracture risk factors. Review whether you still need the PPI or if a lower dose would work. These recommendations have moderate confidence because they’re based on observational studies rather than randomized trials, but the biological mechanisms are well-established.
People taking PPIs regularly for heartburn, acid reflux, or ulcers should pay attention, especially those over 50, postmenopausal women, and people with family histories of osteoporosis. People scheduled for hip or knee replacement should mention PPI use to their surgeon. People with existing bone weakness or previous fractures should be cautious about long-term PPI use. This research is less relevant for people taking PPIs occasionally or for short periods (under 3 months)
Bone damage from PPIs develops gradually over months to years, so you won’t notice immediate effects. Fracture risk increases noticeably after 1 to 2 years of continuous use. Bone density changes take 6 to 12 months to measure with screening tests. If you start calcium and vitamin D supplementation, bone strength improvements take 6 to 12 months to develop. Stopping PPIs allows nutrient absorption to improve within weeks, though bone recovery takes longer
Frequently Asked Questions
Can stomach acid medication cause weak bones?
Yes, proton pump inhibitors can weaken bones by reducing calcium and magnesium absorption and disrupting bone cell activity. Long-term use increases fracture risk, particularly in people over 50 or with existing bone weakness.
How long do you have to take PPIs before bones are affected?
Bone damage from PPIs develops gradually, with increased fracture risk becoming noticeable after 1 to 2 years of continuous use. The longer you take these medications, the greater the risk to bone health.
What can I do to protect my bones if I take PPIs?
Take calcium (1000-1200 mg daily) and vitamin D (600-800 IU daily) supplements, do weight-bearing exercise, and discuss bone density screening with your doctor. Ask whether you still need the PPI or if a lower dose would work.
Do all stomach acid medications damage bones?
This review focused specifically on proton pump inhibitors. Other acid-reducing medications like H2 blockers may have different effects, so discuss your specific medication with your doctor.
Is it safe to stop taking PPIs to protect my bones?
Don’t stop PPIs without talking to your doctor first. They can help you weigh bone health risks against your need for acid reduction and may suggest alternatives or lower doses that work for your situation.
Want to Apply This Research?
- Log daily PPI use and calcium intake. Track any bone pain, joint stiffness, or falls. Record bone density screening results and dates. Monitor vitamin D and B12 supplement compliance
- Set reminders to take calcium and vitamin D supplements with meals. Schedule annual check-ins with your doctor to review whether PPI use is still necessary. Log weekly weight-bearing exercise like walking or strength training to support bone health. Track any new joint pain or mobility changes
- Create a quarterly review of PPI necessity with your healthcare provider. Schedule bone density screening every 1 to 2 years if you’re a long-term PPI user over age 50. Monitor supplement intake consistency. Track fracture risk factors and report any falls or injuries promptly
This article summarizes a narrative review of existing research and is not a substitute for professional medical advice. Proton pump inhibitors remain important medications for many people with acid reflux and ulcers. Do not stop taking PPIs or change your dose without consulting your doctor. If you take PPIs regularly, discuss bone health screening and supplementation with your healthcare provider. This information is for educational purposes and should not be used to diagnose or treat any medical condition. Individual risks and benefits vary based on your personal health history, age, and other medications.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.